Final Thoughts Nausea, constipation, and fatigue can happen during GLP-1 therapy, but they should not be ignored when they interfere with hydration, nutrition, muscle preservation, or daily function
Read on for answers to top questions
Historically, GLP-1 receptor agonists were firmly embedded within endocrinology
Meta Description: Explore NAD+ and AOD9604 for health in 2025
Retatrutide Overview Retatrutide is a first-in-class investigational compound developed by Eli Lilly, currently being studied for its potential role in managing complex metabolic conditions, including obesity, type 2 diabetes, and fatty liver disease
Tracked shipping is included